Eterna Therapeutics stock price
NASDAQ:ERNA · Nasdaq · Healthcare · sector #16Eterna Therapeutics's chart data is dated 2026-10-21. Recorded technical signals: RSI rebound, MACD bullish cross. The display ticker is ERNA.
Eterna Therapeutics last closed at $2.11 (-5.80%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -0.2×. Its overall grade ranks 724 of 727 stocks in Healthcare.
About this company
Eterna Therapeutics last closed at $2.11 (-5.80%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall F · 724/727
Valuation grade C
Related stocks
- AstraZenecaCompetitor
- NovartisCompetitor
- Bristol Myers SquibbCompetitor
About Eterna Therapeutics
- What technical signals does Eterna Therapeutics (ERNA) have?
- Eterna Therapeutics current technical signals: RSI rebound, MACD bullish cross.
- Is Eterna Therapeutics a cup-and-handle pattern?
- No. Eterna Therapeutics has no valid Cup signal right now.
- What published figures are available for Eterna Therapeutics?
- Market cap: $0.66M. Trailing 12 months PER: -0.2×. Latest quarter PBR: 0.78×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-22 dataset
Turn what you saw on this name into a strategy
Ask Q about Eterna Therapeutics, or open the plan table on the main site.
Ask Q about Eterna Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.